nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abdominal Imaging in pregnancy (maternal and foetal risks)
|
Flanagan, Emma |
|
|
42-43 |
C |
p. |
artikel |
2 |
Acute severe ulcerative colitis: State of the art treatment
|
Gisbert, Javier P. |
|
2018 |
42-43 |
C |
p. 59-69 |
artikel |
3 |
Advanced strategies for intensive care management of acute liver failure
|
Saner, Fuat H. |
|
|
42-43 |
C |
p. |
artikel |
4 |
Advances towards gastric cancer screening: Novel devices and biomarkers
|
Lopes, Catarina |
|
|
42-43 |
C |
p. |
artikel |
5 |
Adverse effects of immunosuppression after liver transplantation
|
Noble, Johan |
|
|
42-43 |
C |
p. |
artikel |
6 |
Alcohol and other substance use after liver transplant
|
Winder, Gerald Scott |
|
|
42-43 |
C |
p. |
artikel |
7 |
An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management
|
Smith, Padraic |
|
|
42-43 |
C |
p. |
artikel |
8 |
Applications of endoscopic vacuum therapy in the lower gastrointestinal tract: Tips and tricks and a review of the literature
|
Kouladouros, Konstantinos |
|
|
42-43 |
C |
p. |
artikel |
9 |
Artificial Intelligence for gastrointestinal endoscopy: When technology meets our needs!
|
Hassan, Cesare |
|
|
42-43 |
C |
p. |
artikel |
10 |
Artificial intelligence in biliopancreatic endoscopy: Is there any role?
|
Ahmad, Omer F. |
|
|
42-43 |
C |
p. |
artikel |
11 |
Artificial intelligence in early screening for esophageal squamous cell carcinoma
|
Yan, Si-yan |
|
|
42-43 |
C |
p. |
artikel |
12 |
Artificial intelligence: Thinking outside the box
|
Tontini, Gian Eugenio |
|
|
42-43 |
C |
p. |
artikel |
13 |
Barrett esophagus: What to expect from Artificial Intelligence?
|
Ebigbo, Alanna |
|
|
42-43 |
C |
p. |
artikel |
14 |
Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives
|
Provoost, Nanda |
|
|
42-43 |
C |
p. |
artikel |
15 |
Basic concepts in the management of Acute Liver Failure
|
Auzinger, Georg |
|
|
42-43 |
C |
p. |
artikel |
16 |
Biobetters and biosimilars in inflammatory bowel disease
|
Fanizza, Jacopo |
|
|
42-43 |
C |
p. |
artikel |
17 |
Biosimilars in ulcerative colitis: When and for who?
|
Ilias, Akos |
|
2018 |
42-43 |
C |
p. 35-42 |
artikel |
18 |
Can IL-23 be a good target for ulcerative colitis?
|
Allocca, Mariangela |
|
2018 |
42-43 |
C |
p. 95-102 |
artikel |
19 |
“Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?”
|
Varyani, Fumi |
|
2019 |
42-43 |
C |
p. |
artikel |
20 |
Can we move directly from 5-ASA to a biologic agent in ulcerative colitis?
|
Hindryckx, Pieter |
|
2018 |
42-43 |
C |
p. 9-15 |
artikel |
21 |
Cardiovascular and metabolic disease in the liver transplant recipient
|
Kim, Nathan G. |
|
|
42-43 |
C |
p. |
artikel |
22 |
Cell therapy in congenital inherited hepatic disorders
|
Anand, Hanish |
|
|
42-43 |
C |
p. |
artikel |
23 |
Changes to gastrointestinal function after surgery for colorectal cancer
|
Lam, David |
|
|
42-43 |
C |
p. |
artikel |
24 |
Changing epidemiology and etiology of upper and lower gastrointestinal bleeding
|
Oakland, Kathryn |
|
|
42-43 |
C |
p. |
artikel |
25 |
Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer
|
van den Ende, Tom |
|
2018 |
42-43 |
C |
p. 45-52 |
artikel |
26 |
Chronic diarrhoea in an oncology patient – Clinical assessment and decision making
|
Fernandes, Darren CR. |
|
|
42-43 |
C |
p. |
artikel |
27 |
Chronic pancreatitis and nutritional support
|
Campagnola, Pietro |
|
|
42-43 |
C |
p. |
artikel |
28 |
Coagulopathy in acute liver failure
|
Roy, Akash |
|
|
42-43 |
C |
p. |
artikel |
29 |
Colorectal cancer prevention in patients with ulcerative colitis
|
Lopez, Anthony |
|
2018 |
42-43 |
C |
p. 103-109 |
artikel |
30 |
Colorectal polyp characterization with endocytoscopy: Ready for widespread implementation with artificial intelligence?
|
Barua, Ishita |
|
|
42-43 |
C |
p. |
artikel |
31 |
Colorectal polyp characterization with standard endoscopy: Will Artificial Intelligence succeed where human eyes failed?
|
Parsa, Nasim |
|
|
42-43 |
C |
p. |
artikel |
32 |
Complications and management of interventional endoscopic ultrasound: A critical review
|
Fabbri, Carlo |
|
|
42-43 |
C |
p. |
artikel |
33 |
Complications related to third space endoscopic procedures
|
El Abiad, Rami |
|
|
42-43 |
C |
p. |
artikel |
34 |
Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions)
|
Peretti, Noel |
|
|
42-43 |
C |
p. |
artikel |
35 |
Congenital enteropathies involving defects in enterocyte structure or differentiation
|
Goulet, Olivier |
|
|
42-43 |
C |
p. |
artikel |
36 |
Congenital gastrointestinal disorders. Why is it relevant to adult gastroenterologists?
|
Gottrand, F. |
|
|
42-43 |
C |
p. |
artikel |
37 |
Considerations in case of suspected anastomotic leakage in the lower GI tract
|
de Wit, A. |
|
|
42-43 |
C |
p. |
artikel |
38 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
39 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
40 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
41 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
42 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
43 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
44 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
45 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
46 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
47 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
48 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
49 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
50 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
51 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
52 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
53 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
54 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
55 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
56 |
Copyright Information
|
|
|
|
42-43 |
C |
p. |
artikel |
57 |
CORRIGENDUM TO ‘immunosuppression in liver and intestinal transplantation’
|
Lerut, Jan P. |
|
|
42-43 |
C |
p. |
artikel |
58 |
Cost effectiveness analysis of Barrett's esophagus screening: A systematic review
|
Matchett, Caroline L. |
|
|
42-43 |
C |
p. |
artikel |
59 |
Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
|
Lansdorp-Vogelaar, Iris |
|
|
42-43 |
C |
p. |
artikel |
60 |
Cost-effectiveness of upper endoscopy for gastric cancer screening and surveillance in Western populations
|
Kapteijn, N.E.A. |
|
|
42-43 |
C |
p. |
artikel |
61 |
Cricopharyngeal achalasia and upper oesophageal endoscopic myotomy (CP-POEM)
|
Albeniz, Eduardo |
|
|
42-43 |
C |
p. |
artikel |
62 |
Curative criteria for endoscopic treatment of colorectal cancer
|
Quénéhervé, Lucille |
|
|
42-43 |
C |
p. |
artikel |
63 |
Curative criteria for endoscopic treatment of gastric cancer
|
Cunha Neves, João A. |
|
|
42-43 |
C |
p. |
artikel |
64 |
Curative criteria for endoscopic treatment of oesophageal adenocarcinoma
|
Maan, Annemijn D.I. |
|
|
42-43 |
C |
p. |
artikel |
65 |
Curative criteria for endoscopic treatment of oesophageal squamous cell cancer
|
Iizuka, Toshiro |
|
|
42-43 |
C |
p. |
artikel |
66 |
Definitions, etiopathogenesis and epidemiology of ALF
|
Biswas, Sagnik |
|
|
42-43 |
C |
p. |
artikel |
67 |
De novo and recurrent liver disease
|
Ip, Stephen |
|
|
42-43 |
C |
p. |
artikel |
68 |
De novo and recurrent malignancy
|
Shalaby, Sarah |
|
|
42-43 |
C |
p. |
artikel |
69 |
Detection of flat colorectal neoplasia by artificial intelligence: A systematic review
|
Yamada, Masayoshi |
|
|
42-43 |
C |
p. |
artikel |
70 |
Diagnosis and management of mid-gut (small-bowel) diseases: The state of the art in 2023
|
Despott, Edward J. |
|
|
42-43 |
C |
p. |
artikel |
71 |
Diagnosis and management of small-bowel bleeding
|
Pennazio, Marco |
|
|
42-43 |
C |
p. |
artikel |
72 |
Dietary factors involved in GERD management
|
Fox, Mark |
|
|
42-43 |
C |
p. |
artikel |
73 |
Digestive outcomes in Cystic fibrosis
|
Ley, Delphine |
|
|
42-43 |
C |
p. |
artikel |
74 |
Early detection of gastric cancer beyond endoscopy - new methods
|
Leja, Mārcis |
|
|
42-43 |
C |
p. |
artikel |
75 |
Early detection of pancreatobiliary cancers: How to unveil a silent epidemic to change the outcomes - Preface
|
Vanella, Giuseppe |
|
|
42-43 |
C |
p. |
artikel |
76 |
Early diagnosis of gastric cancer: Endoscopy and artificial intelligence
|
Gonçalves, N. |
|
|
42-43 |
C |
p. |
artikel |
77 |
Early gastric cancer and Artificial Intelligence: Is it time for population screening?
|
Arribas Anta, Julia |
|
|
42-43 |
C |
p. |
artikel |
78 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
79 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
80 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
81 |
Editorial Board
|
|
|
2018 |
42-43 |
C |
p. ii |
artikel |
82 |
Editorial Board
|
|
|
2018 |
42-43 |
C |
p. ii |
artikel |
83 |
Editorial Board
|
|
|
2018 |
42-43 |
C |
p. ii |
artikel |
84 |
Editorial Board
|
|
|
2019 |
42-43 |
C |
p. |
artikel |
85 |
Editorial Board
|
|
|
2019 |
42-43 |
C |
p. |
artikel |
86 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
87 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
88 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
89 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
90 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
91 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
92 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
93 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
94 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
95 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
96 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
97 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
98 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
99 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
100 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
101 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
102 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
103 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
104 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
105 |
Editorial Board
|
|
|
|
42-43 |
C |
p. |
artikel |
106 |
Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease
|
Wieringa, J.W. |
|
|
42-43 |
C |
p. |
artikel |
107 |
Effect of frequently prescribed drugs on gastric cancer risk
|
Weltermann, Theresa |
|
|
42-43 |
C |
p. |
artikel |
108 |
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma
|
Peristeri, Dimitra V. |
|
|
42-43 |
C |
p. |
artikel |
109 |
Emerging indications for third space endoscopy
|
Shah, Rahil H. |
|
|
42-43 |
C |
p. |
artikel |
110 |
Endoscopic management of dysplasia and early oesophageal cancer
|
Zeki, S.S. |
|
2018 |
42-43 |
C |
p. 27-36 |
artikel |
111 |
Endoscopic management of intraprocedural bleeding during endoscopic interventions
|
Alali, Ali A. |
|
|
42-43 |
C |
p. |
artikel |
112 |
Endoscopic management of nonvariceal upper gastrointestinal bleeding
|
Cañamares-Orbís, Pablo |
|
|
42-43 |
C |
p. |
artikel |
113 |
Endoscopic management of surgical complications
|
Goyal, Mayank |
|
|
42-43 |
C |
p. |
artikel |
114 |
Endoscopic pyloromyotomy for treatment of gastroparesis: A new standard or still an experimental approach?
|
Vasatko, Martin |
|
|
42-43 |
C |
p. |
artikel |
115 |
Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques
|
Cecinato, Paolo |
|
|
42-43 |
C |
p. |
artikel |
116 |
Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy
|
Honing, Judith |
|
|
42-43 |
C |
p. |
artikel |
117 |
Endoscopic resection of residual rectal neoplasia after definitive chemoradiotherapy for rectal cancer
|
Klimkowski, Robert |
|
|
42-43 |
C |
p. |
artikel |
118 |
Endoscopic retrograde cholangiopancreatography: A comprehensive review as a single diagnostic tool
|
Papaefthymiou, Apostolis |
|
|
42-43 |
C |
p. |
artikel |
119 |
Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease
|
Hart, Lara |
|
2019 |
42-43 |
C |
p. |
artikel |
120 |
Endoscopic suturing and clipping devices for defects in the GI tract
|
Papaefthymiou, Apostolis |
|
|
42-43 |
C |
p. |
artikel |
121 |
Endoscopic ultrasonography: Enhancing diagnostic accuracy
|
Iglesias-Garcia, Julio |
|
|
42-43 |
C |
p. |
artikel |
122 |
Endoscopic Ultrasound armamentarium for precise and early diagnosis of biliopancreatic lesions
|
Iglesias-Garcia, Julio |
|
|
42-43 |
C |
p. |
artikel |
123 |
Endoscopic ultrasound guided access procedures following surgery
|
Elfert, Khaled |
|
|
42-43 |
C |
p. |
artikel |
124 |
Endoscopic ultrasound guided biliary interventions
|
Dell’Anna, Giuseppe |
|
|
42-43 |
C |
p. |
artikel |
125 |
Endoscopic ultrasound in the management of acute cholecystitis
|
Teh, J.L. |
|
|
42-43 |
C |
p. |
artikel |
126 |
Ensuring timely detection of neoplastic transformation by surveilling chronic pancreatitis
|
Vujasinovic, Miroslav |
|
|
42-43 |
C |
p. |
artikel |
127 |
Esophageal squamous dysplasia and cancer: Is artificial intelligence our best weapon?
|
Hussein, Mohamed |
|
|
42-43 |
C |
p. |
artikel |
128 |
EUS-guided celiac plexus neurolysis for pancreas cancer – Finally established or still under review?
|
Wyse, Jonathan M. |
|
|
42-43 |
C |
p. |
artikel |
129 |
EUS-guided intra-tumoral therapies
|
Marc, Barthet |
|
|
42-43 |
C |
p. |
artikel |
130 |
EUS-guided transenteric pancreatic duct drainage
|
Giovannini, M. |
|
|
42-43 |
C |
p. |
artikel |
131 |
Evaluation and management of neurological complications in acute liver failure
|
Ansari, Nuruddin |
|
|
42-43 |
C |
p. |
artikel |
132 |
Evolution of our understanding of PBC
|
Tanaka, Atsushi |
|
2018 |
42-43 |
C |
p. 3-9 |
artikel |
133 |
Evolution of treatment targets in Crohn’s disease
|
White, Jonathan R. |
|
2019 |
42-43 |
C |
p. |
artikel |
134 |
Evolving strategies and goals of treatment in ulcerative colitis
|
Allocca, Mariangela |
|
2018 |
42-43 |
C |
p. 1-2 |
artikel |
135 |
Familial and hereditary gastric cancer, an overview
|
Carneiro, Fátima |
|
|
42-43 |
C |
p. |
artikel |
136 |
Familial colorectal cancer
|
Mangas-Sanjuan, Carolina |
|
|
42-43 |
C |
p. |
artikel |
137 |
Follow-up of liver transplant recipients
|
Neuberger, James |
|
|
42-43 |
C |
p. |
artikel |
138 |
Food elimination diets in eosinophilic esophagitis: Practical tips in current management and future directions
|
Visaggi, Pierfrancesco |
|
|
42-43 |
C |
p. |
artikel |
139 |
Futures perspectives and therapeutic applications
|
Monino, Laurent |
|
|
42-43 |
C |
p. |
artikel |
140 |
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) – A Helicobacter-opposite point
|
Tacheci, Ilja |
|
|
42-43 |
C |
p. |
artikel |
141 |
Gastric cancer- endoscopic treatment of early lesions, the West learns from the East
|
Prinz, Friederike |
|
|
42-43 |
C |
p. |
artikel |
142 |
Gastrointestinal aspects of Peutz-Jeghers syndrome
|
Latchford, A.R. |
|
|
42-43 |
C |
p. |
artikel |
143 |
Gastrointestinal manifestations in PTEN hamartoma tumor syndrome
|
D'Ermo, Giuseppe |
|
|
42-43 |
C |
p. |
artikel |
144 |
Gastrointestinal side effects of upper gastrointestinal cancer surgery
|
Antonowicz, S. |
|
|
42-43 |
C |
p. |
artikel |
145 |
Genetic landscape for screening and early diagnosis of pancreatic ductal adenocarcinoma: is there a signature?
|
Campa, Daniele |
|
|
42-43 |
C |
p. |
artikel |
146 |
Geoepidemiology and (epi-)genetics in primary biliary cholangitis
|
Roberto, Rosa |
|
2018 |
42-43 |
C |
p. 11-15 |
artikel |
147 |
Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
|
Garcia-Mateo, Sandra |
|
|
42-43 |
C |
p. |
artikel |
148 |
Gut microbiome in children undergoing hematopoietic stem cell transplantation
|
Józefczuk, Paweł |
|
|
42-43 |
C |
p. |
artikel |
149 |
Gut microbiota in colorectal cancer: From pathogenesis to clinic
|
Fusco, William |
|
|
42-43 |
C |
p. |
artikel |
150 |
Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians
|
Grellier, Nathan |
|
|
42-43 |
C |
p. |
artikel |
151 |
Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit
|
Koletzko, Leandra |
|
2019 |
42-43 |
C |
p. |
artikel |
152 |
Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have?
|
Link, Alexander |
|
|
42-43 |
C |
p. |
artikel |
153 |
Hereditary pancreatic cancer
|
Klatte, Derk C.F. |
|
|
42-43 |
C |
p. |
artikel |
154 |
Hirschsprung disease and Paediatric Intestinal Pseudo-obstruction
|
Chanpong, Atchariya |
|
|
42-43 |
C |
p. |
artikel |
155 |
Historical perspective on needle development: From the past to the future
|
Karstensen, John Gásdal |
|
|
42-43 |
C |
p. |
artikel |
156 |
How to close mucosal incisions?
|
Hustak, Rastislav |
|
|
42-43 |
C |
p. |
artikel |
157 |
How to measure quality in capsule endoscopy
|
Salvi, Daniele |
|
|
42-43 |
C |
p. |
artikel |
158 |
How to measure quality in device-assisted enteroscopy
|
Cortegoso Valdivia, Pablo |
|
|
42-43 |
C |
p. |
artikel |
159 |
How to measure quality in ERCP?
|
Ana Rita, Franco |
|
|
42-43 |
C |
p. |
artikel |
160 |
How to measure quality in upper GI endoscopy
|
Romańczyk, Marcin |
|
|
42-43 |
C |
p. |
artikel |
161 |
IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?
|
Ma, Christopher |
|
2019 |
42-43 |
C |
p. |
artikel |
162 |
Immunosuppressants and immune modulators in luminal gastroenterology
|
Forbes, Alastair |
|
|
42-43 |
C |
p. |
artikel |
163 |
Immunosuppression in gastroenterology and hepatology
|
Neuberger, James |
|
|
42-43 |
C |
p. |
artikel |
164 |
Immunosuppression in liver and intestinal transplantation
|
Lerut, Jan P. |
|
|
42-43 |
C |
p. |
artikel |
165 |
Immunosuppression in liver transplant
|
Di Maira, Tommaso |
|
|
42-43 |
C |
p. |
artikel |
166 |
Immunosuppressive drugs modes of action
|
Meneghini, Maria |
|
|
42-43 |
C |
p. |
artikel |
167 |
Immunotherapy induced enterocolitis and gastritis – What to do and when?
|
Cheung, Vincent Ting Fung |
|
|
42-43 |
C |
p. |
artikel |
168 |
Impact of artificial intelligence on colorectal polyp detection
|
Antonelli, Giulio |
|
|
42-43 |
C |
p. |
artikel |
169 |
Impact of gastric cancer treatment on quality of life of patients
|
Schütte, Kerstin |
|
|
42-43 |
C |
p. |
artikel |
170 |
Improving prognosis in primary biliary cholangitis – Therapeutic options and strategy
|
Harms, Maren H. |
|
2018 |
42-43 |
C |
p. 85-94 |
artikel |
171 |
Increased risk of oesophageal squamous cell carcinoma development
|
Maan, Annemijn D.I. |
|
|
42-43 |
C |
p. |
artikel |
172 |
Infections in acute liver failure – Assessment, prevention, and management
|
Venkatakrishnan, Guhan |
|
|
42-43 |
C |
p. |
artikel |
173 |
Inherited pancreatic exocrine insufficiency and pancreatitis: When children transition to adult care
|
Scheers, Isabelle |
|
|
42-43 |
C |
p. |
artikel |
174 |
Integrating artificial intelligence with endoscopic ultrasound in the early detection of bilio-pancreatic lesions: Current advances and future prospects
|
Tacelli, Matteo |
|
|
42-43 |
C |
p. |
artikel |
175 |
Interfering with leukocyte trafficking in Crohn's disease
|
Biswas, Sujata |
|
2019 |
42-43 |
C |
p. |
artikel |
176 |
In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease
|
Meserve, Joseph |
|
2019 |
42-43 |
C |
p. |
artikel |
177 |
Introduction
|
Arcidiacono, Paolo Giorgio |
|
|
42-43 |
C |
p. |
artikel |
178 |
Introduction to care of the liver transplant recipient
|
Neuberger, James M. |
|
|
42-43 |
C |
p. |
artikel |
179 |
Is PBC a viral infectious disease?
|
Mason, Andrew L. |
|
2018 |
42-43 |
C |
p. 27-39 |
artikel |
180 |
Is there still a role for the surgeon in the management of gastrointestinal bleeding ?
|
Donohoe, Claire L. |
|
|
42-43 |
C |
p. |
artikel |
181 |
JAK inhibitors: Novel developments in management of ulcerative colitis
|
Fiorino, Gionata |
|
2018 |
42-43 |
C |
p. 89-93 |
artikel |
182 |
Jejunal access for enteral nutrition: A practical guide for percutaneous endoscopic gastrostomy with jejunal extension and direct percutaneous endoscopic jejunostomy
|
Bourgeois, Amélie |
|
|
42-43 |
C |
p. |
artikel |
183 |
Juvenile polyposis: Focus on less described manifestations
|
Saurin, Jean-Christophe |
|
|
42-43 |
C |
p. |
artikel |
184 |
Juvenile polyposis syndrome: An overview
|
Dal Buono, Arianna |
|
|
42-43 |
C |
p. |
artikel |
185 |
Liver assistive devices in acute liver failure: Current use and future directions
|
Dong, Victor |
|
|
42-43 |
C |
p. |
artikel |
186 |
Liver transplantation in acute liver failure
|
Ichai, Philippe |
|
|
42-43 |
C |
p. |
artikel |
187 |
Long term digestive outcome of œsophageal atresia
|
Aumar, Madeleine |
|
|
42-43 |
C |
p. |
artikel |
188 |
Long-term outcomes of biliary atresia patients surviving with their native livers
|
Hukkinen, Maria |
|
|
42-43 |
C |
p. |
artikel |
189 |
Lynch syndrome; towards more personalized management?
|
Llach, Joan |
|
|
42-43 |
C |
p. |
artikel |
190 |
Management after non-curative endoscopic resection of T1 rectal cancer
|
Dang, Hao |
|
|
42-43 |
C |
p. |
artikel |
191 |
Management of ERCP complications
|
Pal, Partha |
|
|
42-43 |
C |
p. |
artikel |
192 |
Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights
|
Aelvoet, Arthur S. |
|
|
42-43 |
C |
p. |
artikel |
193 |
Management of fistulas in the upper gastrointestinal tract
|
Matteo, Maria Valeria |
|
|
42-43 |
C |
p. |
artikel |
194 |
Management of high risk T1 esophageal adenocarcinoma following endoscopic resection
|
Leclercq, Philippe |
|
|
42-43 |
C |
p. |
artikel |
195 |
Management of high risk T1 gastric adenocarcinoma following endoscopic resection
|
Chaves, Jéssica |
|
|
42-43 |
C |
p. |
artikel |
196 |
Management of iatrogenic perforations during endoscopic interventions in the hepato-pancreatico-biliary tract
|
Boonstra, Kirsten |
|
|
42-43 |
C |
p. |
artikel |
197 |
Management of leakage and fistulas after bariatric surgery
|
Firkins, Stephen A. |
|
|
42-43 |
C |
p. |
artikel |
198 |
Management of non-curative endoscopic resection of T1 colon cancer
|
Bernklev, Linn |
|
|
42-43 |
C |
p. |
artikel |
199 |
Management of perforations during endoscopic resection
|
Alfarone, Ludovico |
|
|
42-43 |
C |
p. |
artikel |
200 |
Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice
|
Colomier, Esther |
|
|
42-43 |
C |
p. |
artikel |
201 |
Microbial dysbiosis in gastric cancer: Association or causation?
|
Huma Arya, Pallavi |
|
|
42-43 |
C |
p. |
artikel |
202 |
Microbiota in gastrointestinal malignancies
|
Bricca, Ludovica |
|
|
42-43 |
C |
p. |
artikel |
203 |
Models and scores to predict adequacy of bowel preparation before colonoscopy
|
Fostier, Romane |
|
|
42-43 |
C |
p. |
artikel |
204 |
Molecular modelling of the gastric barrier response, from infection to carcinogenesis
|
Traulsen, Jan |
|
|
42-43 |
C |
p. |
artikel |
205 |
Molecular pathways in the development and treatment of oesophageal cancer
|
Walker, Robert Charles |
|
2018 |
42-43 |
C |
p. 9-15 |
artikel |
206 |
Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract
|
Seidensticker, Max |
|
|
42-43 |
C |
p. |
artikel |
207 |
Multimodal cancer treatment with endoscopy
|
Kaminski, Michal F. |
|
|
42-43 |
C |
p. |
artikel |
208 |
Multi-modality management of defects in the gastrointestinal tract: Where the endoscope meets the scalpel
|
Pouw, Roos E. |
|
|
42-43 |
C |
p. |
artikel |
209 |
Multi-modality management of defects in the gastrointestinal tract: Where the endoscope meets the scalpel: Endoscopic vacuum therapy in the upper gastrointestinal tract
|
Pattynama, Lisanne M.D. |
|
|
42-43 |
C |
p. |
artikel |
210 |
Multimodal management of foregut neuroendocrine neoplasms
|
Zhou, Yichan |
|
|
42-43 |
C |
p. |
artikel |
211 |
Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma
|
Nabi, Zaheer |
|
|
42-43 |
C |
p. |
artikel |
212 |
Navigating complexities and considerations for suspected anastomotic leakage in the upper gastrointestinal tract: A state of the art review
|
Kamarajah, Sivesh K. |
|
|
42-43 |
C |
p. |
artikel |
213 |
Navigating the learning landscape: Comprehensive training in third space endoscopy - training, techniques, and practical recommendations
|
Roser, D. |
|
|
42-43 |
C |
p. |
artikel |
214 |
Neoadjuvant chemoradiotherapy for resectable oesophageal cancer
|
Eyck, B.M. |
|
2018 |
42-43 |
C |
p. 37-44 |
artikel |
215 |
Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils
|
Singh, Siddharth |
|
2019 |
42-43 |
C |
p. |
artikel |
216 |
New agents for immunosuppression
|
Jefremow, André |
|
|
42-43 |
C |
p. |
artikel |
217 |
New weapons for the management of perianal Crohn's disease
|
Cicerone, Clelia |
|
|
42-43 |
C |
p. |
artikel |
218 |
Non-adherence and transition clinics
|
Kelly, Deirdre |
|
|
42-43 |
C |
p. |
artikel |
219 |
Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery)
|
Arkenbosch, J.H.C. |
|
|
42-43 |
C |
p. |
artikel |
220 |
Non-technical skills in GI endoscopy as a unit quality measure
|
Haycock, Adam |
|
|
42-43 |
C |
p. |
artikel |
221 |
Novel devices and biomarkers in screening for esophageal squamous cell cancer
|
Januszewicz, Wladyslaw |
|
|
42-43 |
C |
p. |
artikel |
222 |
Novel imaging techniques in staging oesophageal cancer
|
Foley, Kieran |
|
2018 |
42-43 |
C |
p. 17-25 |
artikel |
223 |
Nutritional intervention in the management of non-alcoholic fatty liver disease
|
Brunetto, Maurizia R. |
|
|
42-43 |
C |
p. |
artikel |
224 |
Nutrition and gastroenterological support in end of life care
|
Schütte, Kerstin |
|
|
42-43 |
C |
p. |
artikel |
225 |
Nutrition in gastroenterology: Rising evidence and future directions
|
de Bortoli, Nicola |
|
|
42-43 |
C |
p. |
artikel |
226 |
Nutrition in inflammatory bowel diseases; Is there a role?
|
Kaliora, Andriana C. |
|
|
42-43 |
C |
p. |
artikel |
227 |
Oesophagectomy: The expanding role of minimally invasive surgery in oesophageal cancer
|
van den Berg, J.W. |
|
2018 |
42-43 |
C |
p. 75-80 |
artikel |
228 |
Optimal management of the patient presenting with small bowel bleeding
|
Sey, Michael Sai Lai |
|
|
42-43 |
C |
p. |
artikel |
229 |
Optimal timing of endoscopy in patients with acute upper gastrointestinal bleeding
|
Chaudhary, Sardar |
|
|
42-43 |
C |
p. |
artikel |
230 |
Overcoming barriers to implementation of artificial intelligence in gastroenterology
|
Sutton, Richard A. |
|
|
42-43 |
C |
p. |
artikel |
231 |
Palliation of dysphagia
|
van der Bogt, R.D. |
|
2018 |
42-43 |
C |
p. 97-103 |
artikel |
232 |
Pathophysiology of primary biliary cholangitis
|
Gulamhusein, Aliya F. |
|
2018 |
42-43 |
C |
p. 17-25 |
artikel |
233 |
Pathophysiology of the irritable bowel syndrome – Reflections of today
|
Hellström, Per M. |
|
2019 |
42-43 |
C |
p. |
artikel |
234 |
Patient experience as a quality marker in gastrointestinal endoscopy
|
Neilson, L.J. |
|
|
42-43 |
C |
p. |
artikel |
235 |
Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)
|
Janmohamed, Ashnila |
|
2018 |
42-43 |
C |
p. 71-83 |
artikel |
236 |
PBC and related extrahepatic diseases
|
Floreani, Annarosa |
|
2018 |
42-43 |
C |
p. 49-54 |
artikel |
237 |
PBC-transplantation and disease recurrence
|
Nevens, Frederik |
|
2018 |
42-43 |
C |
p. 107-111 |
artikel |
238 |
Perface to special edition: Third space endoscopy
|
Martinek, Jan |
|
|
42-43 |
C |
p. |
artikel |
239 |
Peri-operative patient optimization for oesophageal cancer surgery – From prehabilitation to enhanced recovery
|
Zylstra, J. |
|
2018 |
42-43 |
C |
p. 61-73 |
artikel |
240 |
Per oral endoscopic myotomy for achalasia
|
de Sire, Roberto |
|
|
42-43 |
C |
p. |
artikel |
241 |
Pharmacology, efficacy and safety of JAK inhibitors in Crohn’s disease
|
Ma, Christopher |
|
2019 |
42-43 |
C |
p. |
artikel |
242 |
Pitfalls in training and validation of deep learning systems
|
Eelbode, Tom |
|
|
42-43 |
C |
p. |
artikel |
243 |
Plant-based diets in gastrointestinal diseases: Which evidence?
|
Mazzocchi, Samanta |
|
|
42-43 |
C |
p. |
artikel |
244 |
POEM for non-achalasia spastic oesophageal motility disorders
|
Familiari, Pietro |
|
|
42-43 |
C |
p. |
artikel |
245 |
POEM in the esophagus - How to deal with the post-POEM reflux
|
Ďuriček, Martin |
|
|
42-43 |
C |
p. |
artikel |
246 |
Post-endoscopy upper gastrointestinal cancer: Emerging data and opportunities to improve early detection
|
Ko, Mie Thu |
|
|
42-43 |
C |
p. |
artikel |
247 |
Post liver transplant recurrent and de novo viral infections
|
Jothimani, Dinesh |
|
|
42-43 |
C |
p. |
artikel |
248 |
Pouch surgery for ulcerative colitis in 2025: A narrative review
|
Vignali, Andrea |
|
|
42-43 |
C |
p. |
artikel |
249 |
Preconception counseling of females with inflammatory bowel disease
|
Rottenstreich, Amihai |
|
|
42-43 |
C |
p. |
artikel |
250 |
Predictive models in EUS/ERCP
|
Lattanzi, Barbara |
|
|
42-43 |
C |
p. |
artikel |
251 |
Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation
|
Milić, Sandra |
|
|
42-43 |
C |
p. |
artikel |
252 |
Preface
|
Saigal, Sanjiv |
|
|
42-43 |
C |
p. |
artikel |
253 |
Preface - Evolving approaches to the evaluation and management of Crohn’s disease
|
Jairath, Vipul |
|
2019 |
42-43 |
C |
p. |
artikel |
254 |
Preface - Functional gastrointestinal disorders
|
Hellström, Per M. |
|
2019 |
42-43 |
C |
p. |
artikel |
255 |
Preface – Gastrointestinal bleeding
|
Jairath, Vipul |
|
|
42-43 |
C |
p. |
artikel |
256 |
Preface Hereditary disorders
|
van Leerdam, Monique E. |
|
|
42-43 |
C |
p. |
artikel |
257 |
Preface immunosuppression in gastroenterology and hepatology
|
Neuberger, James |
|
|
42-43 |
C |
p. |
artikel |
258 |
Preface “Oesophageal cancer”
|
Wijnhoven, Bas |
|
2018 |
42-43 |
C |
p. 1 |
artikel |
259 |
Preface: Pregnancy in GI-disorders
|
Van der Woude, C.J. |
|
|
42-43 |
C |
p. |
artikel |
260 |
Preface - Primary Biliary Cholangitis
|
van Buuren, Henk R. |
|
2018 |
42-43 |
C |
p. 1 |
artikel |
261 |
Preface to issue ‘Quality in Endoscopy'
|
Regula, Jaroslaw |
|
|
42-43 |
C |
p. |
artikel |
262 |
Preface to special edition: Microbiome, inflammation and cancer
|
Mullish, Benjamin H. |
|
|
42-43 |
C |
p. |
artikel |
263 |
Preface to special edition: Screening and Early diagnosis of upper gastrointestinal neoplastic lesions
|
Honing, J. |
|
|
42-43 |
C |
p. |
artikel |
264 |
Preface to special edition: The management of GI endoscopy complications
|
Longcroft-Wheaton, Gaius |
|
|
42-43 |
C |
p. |
artikel |
265 |
Pregnancy and IBD: A practical guide for physicians
|
Freitas Queiroz, Natália Sousa |
|
|
42-43 |
C |
p. |
artikel |
266 |
Prevention of delayed bleeding after resection of large colonic polyps
|
Htet, Hein |
|
|
42-43 |
C |
p. |
artikel |
267 |
Prevention of post-ERCP complications
|
Triki, Lotfi |
|
|
42-43 |
C |
p. |
artikel |
268 |
Primary biliary cholangitis and bone disease
|
Parés, Albert |
|
2018 |
42-43 |
C |
p. 63-70 |
artikel |
269 |
Prognostic modelling in IBD
|
Rimmer, Peter |
|
|
42-43 |
C |
p. |
artikel |
270 |
Prognostic models and autoimmune liver diseases
|
D'Amato, Daphne |
|
|
42-43 |
C |
p. |
artikel |
271 |
Prognostic models in acute liver failure-historic evolution and newer updates “prognostic models in acute liver failure”
|
Panackel, Charles |
|
|
42-43 |
C |
p. |
artikel |
272 |
Prognostic models in alcohol-related liver disease and alcohol-related hepatitis
|
Musto, Jessica Ann |
|
|
42-43 |
C |
p. |
artikel |
273 |
Prognostic models in end stage liver disease
|
Ferrarese, A. |
|
|
42-43 |
C |
p. |
artikel |
274 |
Prognostic models – Their use and abuse
|
Neuberger, James |
|
|
42-43 |
C |
p. |
artikel |
275 |
Prognostic models: What the statistician wants the clinician to know
|
Allen, Elisa |
|
|
42-43 |
C |
p. |
artikel |
276 |
Progress in the treatment of cancer patients – don’t forget the gut feeling!
|
Bornschein, Jan |
|
|
42-43 |
C |
p. |
artikel |
277 |
Proton pump inhibitors for upper gastrointestinal bleeding
|
Kherad, Omar |
|
|
42-43 |
C |
p. |
artikel |
278 |
Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome
|
Lindberg, Greger |
|
2019 |
42-43 |
C |
p. |
artikel |
279 |
Publisher's note
|
Wetherell, Victoria |
|
2019 |
42-43 |
C |
p. |
artikel |
280 |
Quality assessment in endoscopy “artificial intelligence in endoscopy”
|
Mori, Yuchi |
|
|
42-43 |
C |
p. |
artikel |
281 |
Quality in endoscopy training
|
Anderson, John |
|
|
42-43 |
C |
p. |
artikel |
282 |
Quality in EUS: for many but not for all
|
Fusaroli, Pietro |
|
|
42-43 |
C |
p. |
artikel |
283 |
Quality in screening colonoscopy
|
Sztogrin-Pluta, Aleksandra |
|
|
42-43 |
C |
p. |
artikel |
284 |
Quality of life after liver transplantation
|
Åberg, Fredrik |
|
|
42-43 |
C |
p. |
artikel |
285 |
Quality parameters of colorectal polypectomy
|
Zessner-Spitzenberg, Jasmin |
|
|
42-43 |
C |
p. |
artikel |
286 |
Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options
|
Araujo, Isis K. |
|
|
42-43 |
C |
p. |
artikel |
287 |
Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options
|
Afifi, Ahmed N.A.M. |
|
|
42-43 |
C |
p. |
artikel |
288 |
Radiomics in early detection of bilio-pancreatic lesions: A narrative review
|
Casà, Calogero |
|
|
42-43 |
C |
p. |
artikel |
289 |
Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?
|
Solitano, Virginia |
|
|
42-43 |
C |
p. |
artikel |
290 |
Recent progress in gastric cancer prevention
|
Park, Jin Young |
|
|
42-43 |
C |
p. |
artikel |
291 |
Recent progress in the understanding of gastric cancer – Do patients experience a benefit yet?
|
Bornschein, Jan |
|
|
42-43 |
C |
p. |
artikel |
292 |
Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
|
Bogdanski, Aleksander M. |
|
|
42-43 |
C |
p. |
artikel |
293 |
Reducing the burden of pancreatic cancer by surveilling mucinous cystic neoplasms: are we there yet?
|
De Stefano, Federico |
|
|
42-43 |
C |
p. |
artikel |
294 |
Reducing the incidence of pancreatic cancer through radiofrequency ablation of mucinous cystic neoplasms: What is the evidence?
|
Kudaravalli, Pujitha |
|
|
42-43 |
C |
p. |
artikel |
295 |
Reflux esophagitis, functional and non-functional
|
Bor, Serhat |
|
2019 |
42-43 |
C |
p. |
artikel |
296 |
Refractory ulcerative proctitis: How to treat it?
|
Pineton de Chambrun, Guillaume |
|
2018 |
42-43 |
C |
p. 49-57 |
artikel |
297 |
Regenerative medicine for childhood gastrointestinal diseases
|
Jones, Brendan C. |
|
|
42-43 |
C |
p. |
artikel |
298 |
Renal disease in the allograft recipient
|
Nevens, Frederik |
|
|
42-43 |
C |
p. |
artikel |
299 |
Risk factors for oesophageal cancer
|
Xie, Shao-Hua |
|
2018 |
42-43 |
C |
p. 3-8 |
artikel |
300 |
Risk stratification and prognostic modelling in primary biliary cholangitis
|
Goet, Jorn C. |
|
2018 |
42-43 |
C |
p. 95-106 |
artikel |
301 |
Risk stratification in upper and upper and lower GI bleeding: Which scores should we use?
|
Oakland, Kathryn |
|
|
42-43 |
C |
p. |
artikel |
302 |
Robot assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer
|
van der Sluis, Pieter Christiaan |
|
2018 |
42-43 |
C |
p. 81-83 |
artikel |
303 |
Role of Low-FODMAP diet in functional dyspepsia: “Why”, “When”, and “to Whom”
|
Rettura, Francesco |
|
|
42-43 |
C |
p. |
artikel |
304 |
Safe, non-surgical retrieval of foreign bodies from the small bowel
|
Riccioni, Maria Elena |
|
|
42-43 |
C |
p. |
artikel |
305 |
Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
|
Bonovas, Stefanos |
|
2018 |
42-43 |
C |
p. 43-47 |
artikel |
306 |
Scoring systems for risk stratification in upper and lower gastrointestinal bleeding
|
Radaelli, Franco |
|
|
42-43 |
C |
p. |
artikel |
307 |
Screening and surveillance of hereditary upper GI cancers
|
Wu, Lianlian |
|
|
42-43 |
C |
p. |
artikel |
308 |
Screening for and surveillance of premalignant conditions of the stomach
|
Luzko, Irina |
|
|
42-43 |
C |
p. |
artikel |
309 |
Serrated polyposis syndrome; epidemiology and management
|
Carballal, S. |
|
|
42-43 |
C |
p. |
artikel |
310 |
Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?
|
Pouillon, Lieven |
|
2018 |
42-43 |
C |
p. 17-25 |
artikel |
311 |
Should we use vedolizumab as mono or combo therapy in ulcerative colitis?
|
Hedin, Charlotte |
|
2018 |
42-43 |
C |
p. 27-34 |
artikel |
312 |
Small Bowel Capsule Endoscopy and artificial intelligence: First or second reader?
|
Piccirelli, Stefania |
|
|
42-43 |
C |
p. |
artikel |
313 |
Striving for quality improvement: can artificial intelligence help?
|
Sinonquel, P. |
|
|
42-43 |
C |
p. |
artikel |
314 |
Surgery in ulcerative colitis: When? How?
|
Gallo, Gaetano |
|
2018 |
42-43 |
C |
p. 71-78 |
artikel |
315 |
Symptoms of PBC – Pathophysiology and management
|
Khanna, Amardeep |
|
2018 |
42-43 |
C |
p. 41-47 |
artikel |
316 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
317 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
318 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
319 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
320 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
321 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
322 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
323 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
324 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
325 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
326 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
327 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
328 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
329 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
330 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
331 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
332 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
333 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
334 |
Table of Contents
|
|
|
|
42-43 |
C |
p. |
artikel |
335 |
Tangible pathologies in functional dyspepsia
|
Walker, Marjorie M. |
|
2019 |
42-43 |
C |
p. |
artikel |
336 |
Targeted and immunotherapy in the era of personalised gastric cancer treatment
|
Catanese, Silvia |
|
|
42-43 |
C |
p. |
artikel |
337 |
Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?
|
Ma, Christopher |
|
2019 |
42-43 |
C |
p. |
artikel |
338 |
Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future
|
Webb, Dominic-Luc |
|
2019 |
42-43 |
C |
p. |
artikel |
339 |
The complexity of cancer origins at the gastro-oesophageal junction
|
Bornschein, Jan |
|
|
42-43 |
C |
p. |
artikel |
340 |
The contribution of EUS to the management of endoscopic and surgical complications
|
Tehami, N. |
|
|
42-43 |
C |
p. |
artikel |
341 |
The endoscopic management of oesophageal strictures
|
Norton, Benjamin Charles |
|
|
42-43 |
C |
p. |
artikel |
342 |
The evolving role of device-assisted enteroscopy: The state of the art as of August 2023
|
Yamamoto, Hironori |
|
|
42-43 |
C |
p. |
artikel |
343 |
The evolving role of small-bowel capsule endoscopy
|
Pecere, Silvia |
|
|
42-43 |
C |
p. |
artikel |
344 |
The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer
|
Lauri, Gaetano |
|
|
42-43 |
C |
p. |
artikel |
345 |
The immune system and microbiome in pregnancy
|
Fuhler, G.M. |
|
|
42-43 |
C |
p. |
artikel |
346 |
The impact of biologics in surgical outcomes in ulcerative colitis
|
Argollo, Marjorie C. |
|
2018 |
42-43 |
C |
p. 79-87 |
artikel |
347 |
The impact of modulating the gastrointestinal microbiota in cancer patients
|
Morkūnas, Egidijus |
|
|
42-43 |
C |
p. |
artikel |
348 |
The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease
|
Picardo, Sherman |
|
|
42-43 |
C |
p. |
artikel |
349 |
The impact of recent next generation sequencing and the need for a new classification in gastric cancer
|
Businello, Gianluca |
|
|
42-43 |
C |
p. |
artikel |
350 |
The influence of the gastric microbiota in gastric cancer development
|
Pereira-Marques, Joana |
|
|
42-43 |
C |
p. |
artikel |
351 |
The interpretation of liver function tests in pregnancy
|
Guarino, Maria |
|
|
42-43 |
C |
p. |
artikel |
352 |
The management of mid & proximal oesophageal squamous cell carcinoma
|
Wong, Ian |
|
2018 |
42-43 |
C |
p. 85-90 |
artikel |
353 |
The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders
|
Severino, Andrea |
|
|
42-43 |
C |
p. |
artikel |
354 |
The optimal use of blood components in the management of gastrointestinal bleeding
|
Donovan, Killian |
|
|
42-43 |
C |
p. |
artikel |
355 |
The pros and cons of gastric bypass surgery – The role of the Roux-limb
|
Björklund, Per |
|
2019 |
42-43 |
C |
p. |
artikel |
356 |
Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology
|
Udomkarnjananun, Suwasin |
|
|
42-43 |
C |
p. |
artikel |
357 |
Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS
|
Benno, P. |
|
2019 |
42-43 |
C |
p. |
artikel |
358 |
The role of artificial intelligence in Barrett's esophagus: Current status and future challenges
|
van Eijck van Heslinga, R.A.H. |
|
|
42-43 |
C |
p. |
artikel |
359 |
The role of colonoscopy and endotherapy in the management of lower gastrointestinal bleeding
|
Sengupta, Neil |
|
|
42-43 |
C |
p. |
artikel |
360 |
The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer
|
Jeene, Paul M. |
|
2018 |
42-43 |
C |
p. 53-59 |
artikel |
361 |
The role of diet in inflammatory bowel disease: A comprehensive review of the literature
|
Faggiani, Ilaria |
|
|
42-43 |
C |
p. |
artikel |
362 |
The role of diet in shaping human gut microbiota
|
Rinninella, Emanuele |
|
|
42-43 |
C |
p. |
artikel |
363 |
The role of microbiome in the development of gluten-related disorders
|
Catassi, Giulia |
|
|
42-43 |
C |
p. |
artikel |
364 |
The role of radiology in diagnosing gastrointestinal tract perforation
|
Kulinna-Cosentini, Christiane |
|
|
42-43 |
C |
p. |
artikel |
365 |
The role of surgery in advanced disease for esophageal and junctional cancer
|
Mönig, Stefan |
|
2018 |
42-43 |
C |
p. 91-96 |
artikel |
366 |
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
|
Dean, Nathan J. |
|
|
42-43 |
C |
p. |
artikel |
367 |
The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis
|
Ryan, Thomas |
|
|
42-43 |
C |
p. |
artikel |
368 |
The Rome IV: Irritable bowel syndrome - A functional disorder
|
Hellström, Per M. |
|
2019 |
42-43 |
C |
p. |
artikel |
369 |
The use of endoscopic ultrasound in the diagnosis and management of portal hypertension
|
Laleman, Wim |
|
|
42-43 |
C |
p. |
artikel |
370 |
The use of endoscopic ultrasound in the management of post-surgical and pancreatic fluid collections
|
Trieu, Judy A. |
|
|
42-43 |
C |
p. |
artikel |
371 |
Towards tolerance in liver transplantation
|
Toti, L. |
|
|
42-43 |
C |
p. |
artikel |
372 |
Traditional septotomy or Z-POEM for Zenker's diverticulum
|
Kaminski, M.F. |
|
|
42-43 |
C |
p. |
artikel |
373 |
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicine
|
Sequier, Léa |
|
|
42-43 |
C |
p. |
artikel |
374 |
Treatment targets in IBD: is it time for new strategies?
|
Fanizzi, Fabrizio |
|
|
42-43 |
C |
p. |
artikel |
375 |
“Unraveling the mysteries of IBD: Innovations and insights into the management of Crohn's disease and ulcerative colitis”
|
D'Amico, Ferdinando |
|
|
42-43 |
C |
p. |
artikel |
376 |
Updates in the diagnosis and management of coeliac disease
|
Shiha, Mohamed G. |
|
|
42-43 |
C |
p. |
artikel |
377 |
Updates in the diagnosis and management of non-ampullary small-bowel polyposis
|
Lucaciu, Laura |
|
|
42-43 |
C |
p. |
artikel |
378 |
Updates in the diagnosis and management of small-bowel Crohn's disease
|
Carretero, Cristina |
|
|
42-43 |
C |
p. |
artikel |
379 |
Updates in the diagnosis and management of small-bowel tumors
|
Vlachou, Erasmia |
|
|
42-43 |
C |
p. |
artikel |
380 |
Updates on the diagnosis and management of cryptogenic multifocal ulcerative stenosing enteropathy (CMUSE) and non-steroidal enteropathy
|
Moreels, Tom G. |
|
|
42-43 |
C |
p. |
artikel |
381 |
Use of immunosuppression in non-transplant hepatology
|
Ronca, Vincenzo |
|
|
42-43 |
C |
p. |
artikel |
382 |
Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders
|
Al-Saffar, Ahmad |
|
2019 |
42-43 |
C |
p. |
artikel |
383 |
Variant syndromes of primary biliary cholangitis
|
Schulz, Lisa |
|
2018 |
42-43 |
C |
p. 55-61 |
artikel |
384 |
What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?
|
Ma, Christopher |
|
2019 |
42-43 |
C |
p. |
artikel |
385 |
What is the role of histopathology in the evaluation of disease activity in Crohn's disease?
|
Pai, Rish K. |
|
2019 |
42-43 |
C |
p. |
artikel |
386 |
When all else fails - Radiological management of severe gastrointestinal bleeding
|
Loffroy, Romaric |
|
|
42-43 |
C |
p. |
artikel |
387 |
Which evidence for a treat to target strategy in ulcerative colitis?
|
Marchal Bressenot, Aude |
|
2018 |
42-43 |
C |
p. 3-8 |
artikel |
388 |
Wilson’s disease- management and long term outcomes
|
Socha, Piotr |
|
|
42-43 |
C |
p. |
artikel |